Wells Fargo & Company Lowers Leidos (NYSE:LDOS) Price Target to $197.00

Leidos (NYSE:LDOS) had its price target lowered by Wells Fargo & Company from $199.00 to $197.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the aerospace company’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 43.41% from the stock’s current price.

Several other equities analysts have also issued reports on the company. Robert W. Baird upped their target price on Leidos from $180.00 to $218.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. TD Cowen lowered Leidos from a “buy” rating to a “hold” rating and decreased their target price for the company from $200.00 to $165.00 in a research report on Wednesday, January 8th. Barclays lifted their target price on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Truist Financial reduced their price target on shares of Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a research report on Friday, November 22nd. Finally, Royal Bank of Canada lifted their price objective on shares of Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $179.33.

Leidos Trading Down 3.8 %

Shares of Leidos stock opened at $137.37 on Wednesday. The company has a market capitalization of $18.33 billion, a P/E ratio of 15.65, a price-to-earnings-growth ratio of 0.92 and a beta of 0.66. The stock has a fifty day simple moving average of $149.31 and a 200 day simple moving average of $157.71. Leidos has a 12-month low of $113.67 and a 12-month high of $202.90. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87.

Leidos (NYSE:LDOS) last announced its earnings results on Tuesday, February 11th. The aerospace company reported $2.37 EPS for the quarter, beating the consensus estimate of $2.24 by $0.13. Leidos had a net margin of 7.37% and a return on equity of 30.31%. On average, sell-side analysts anticipate that Leidos will post 10.03 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Leidos news, Director Noel B. Geer acquired 2,000 shares of the business’s stock in a transaction dated Wednesday, November 20th. The stock was bought at an average price of $161.13 per share, with a total value of $322,260.00. Following the completion of the acquisition, the director now owns 2,000 shares of the company’s stock, valued at $322,260. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.96% of the company’s stock.

Institutional Investors Weigh In On Leidos

Several hedge funds have recently bought and sold shares of LDOS. Rakuten Securities Inc. boosted its holdings in shares of Leidos by 1,460.0% in the 3rd quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock worth $25,000 after purchasing an additional 146 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in Leidos in the 3rd quarter worth approximately $29,000. Northwest Investment Counselors LLC purchased a new stake in Leidos in the third quarter worth approximately $30,000. Duncker Streett & Co. Inc. bought a new position in Leidos during the fourth quarter valued at approximately $27,000. Finally, Berbice Capital Management LLC purchased a new position in Leidos in the 4th quarter worth $29,000. 76.12% of the stock is currently owned by institutional investors.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.